Document is current
Any future updates will be listed below
-
Authors
Tetteh, Emmanuel K. https://orcid.org/0000-0002-7892-5914
Aboagye-Mensah, Gifty
Anidi, Nwaliweaku
Geng, Elvin H.
Powell, Byron J.
Proctor, Enola K.
Huffman, Mark D.
Antes, Alison L.
-
Funding
Funding for this research was provided by:
Washington University
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 12 February 2026
First Online: 27 February 2026
Declarations
:
: This study received approval from the Washington University in St. Louis Institutional Review Board (IRB ID#-202403208).
: Not applicable.
: Dr. Huffman has patents pending related to heart failure polypills. George Health Enterprises Pty Ltd (GH) and its subsidiary, George Medicines Pty Ltd, have received investment funds to develop fixed-dose combination products, including combinations of blood pressure-lowering drugs. GH is the social enterprise arm of The George Institute for Global Health. Elvin Geng is the Editor-in-Chief of Implementation Science Communications. All other authors have no disclosures or financial conflicts of interest.
